Trial Profile
Efficacy of the New Insulin Glargine 300 U/mL in patients treated with other basal insulins for type 2 diabetes mellitus in a real world setting
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Sep 2016
Price :
$35
*
At a glance
- Drugs Insulin glargine (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- 16 Sep 2016 New trial record